A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure

By sjmartinez • November 15, 2024

Leong M, Dai T, Tong L, Nast CC. A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure. BMC Nephrol. 2024 Nov 14;25(1):409. doi: 10.1186/s12882-024-03689-6. PMID: 39543462.

Tags: Brentuximab, FAN1, Karyomegalic interstitial nephritis, Nephrology, Publications

Experiences and perspectives of patients and their caregivers on gastrointestinal symptoms in peritoneal dialysis: Workshop report

Hayat A, Johnson DW, Manera K, Viecelli AK, Wilkie M, Shen J, Wang AY, Htay H, Jaure A, Cho Y, Walker R. Experiences and perspectives[...]

Associations Between Donor-derived Cell-free DNA Dynamics and Clinical Outcomes After Kidney Allograft Rejection: A Prospective, Multi-center Study

Bunnapradist S, Leca N, Zaky ZS, Stratta RJ, Khamash HA, Shihab F, Ekwenna O, Aldana-Campos M, Kahwaji J, Biancone L, Maw TT, Biagini DG, Kaur[...]

Clinical characteristics and CKD care delivery in African American and American Indian or Alaska Native patients: A real-world cohort study

Mayhand KN, Alicic RZ, Kornowske LM, Jones CR, Daratha KB, Reynolds CL, Nicholas SB, Thorpe RJ Jr, Bui AAT, Norris KC, Tuttle KR. Clinical characteristics[...]